M88 app Silicon Valley Partner Dr. James Zhu Attended Bio Europe 2015 In Munich

M88 app Silicon Valley partner, Dr. James Zhu, was one of six speakers in the panel titled "The evolving Landscape of China's Pharmaceutical Industry" in BIO EUROPE 2015, which was hosted in the International Congress Center in Munich. Germany, from Nov. 2 to Nov. 4, 2015. BIO Europe is the Europe's largest and most distinguished life science deal-making event serving the global biotechnology industry. This year, more than 3300 executives from early 60 countries participated in BIO Europe.

The panel addressed the opportunities M88 app ChM88 appa which globally impact on multiple dimensions: market sales, new M88 appnovations, talent pools, R&D outsourcM88 appg, public and private source of capitals and entrepreneurial M88 appitiative, given that ChM88 appa's pharmaceutical M88 appdustry has grown at an unprecedented speed along with its boomM88 appg economy. The panel poM88 appted out the drivers to sustaM88 app the contM88 appued growth and discussed whether "M88 appnovated M88 app ChM88 appa" get any closer M88 app replacM88 appg "Made M88 app ChM88 appa". The panel further elaborated the contM88 appued challenges and opportunities M88 app capturM88 appg the growM88 appg market. The session was packed with audience M88 appterested M88 app the ChM88 appese pharmaceutical market.

Dr. James J. Zhu is the head of M88 app Silicon Valley Office and the co-head of patent practice group of M88 app. James' practice includes patent litigation, procurement, opinion, strategies, technology licensing, primarily focusing on life sciences, material sciences, medical devices, and electronics. James is a member of the State Bar of California and a patent attorney registered to practice before the US Patent & Trademark Office. The BusinessWeek elected James as one of most influential "sea turtles" (US returnees) in the Sino-American community. With seven academic years, Dr, Zhu earned Ph.D. degree from Caltech and JD/MBA from Columbia University.